Patel Mehrie Harshad, Sampath Shrikanth, Kapoor Anoushka, Damani Devanshi Narendra, Chellapuram Nikitha, Challa Apurva Bhavana, Kaur Manmeet Pal, Walton Richard D, Stavrakis Stavros, Arunachalam Shivaram P, Kulkarni Kanchan
Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, United States.
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States.
Front Physiol. 2021 Dec 2;12:783241. doi: 10.3389/fphys.2021.783241. eCollection 2021.
Cardiac arrhythmias constitute a tremendous burden on healthcare and are the leading cause of mortality worldwide. An alarming number of people have been reported to manifest sudden cardiac death as the first symptom of cardiac arrhythmias, accounting for about 20% of all deaths annually. Furthermore, patients prone to atrial tachyarrhythmias such as atrial flutter and fibrillation often have associated comorbidities including hypertension, ischemic heart disease, valvular cardiomyopathy and increased risk of stroke. Technological advances in electrical stimulation and sensing modalities have led to the proliferation of medical devices including pacemakers and implantable defibrillators, aiming to restore normal cardiac rhythm. However, given the complex spatiotemporal dynamics and non-linearity of the human heart, predicting the onset of arrhythmias and preventing the transition from steady state to unstable rhythms has been an extremely challenging task. Defibrillatory shocks still remain the primary clinical intervention for lethal ventricular arrhythmias, yet patients with implantable cardioverter defibrillators often suffer from inappropriate shocks due to false positives and reduced quality of life. Here, we aim to present a comprehensive review of the current advances in cardiac arrhythmia prediction, prevention and control strategies. We provide an overview of traditional clinical arrhythmia management methods and describe promising potential pacing techniques for predicting the onset of abnormal rhythms and effectively suppressing cardiac arrhythmias. We also offer a clinical perspective on bridging the gap between basic and clinical science that would aid in the assimilation of promising anti-arrhythmic pacing strategies.
心律失常给医疗保健带来了巨大负担,是全球范围内的主要死亡原因。据报道,数量惊人的人以心脏性猝死作为心律失常的首发症状,约占每年总死亡人数的20%。此外,易患房性快速性心律失常(如心房扑动和心房颤动)的患者通常伴有包括高血压、缺血性心脏病、瓣膜性心肌病等合并症,且中风风险增加。电刺激和传感方式的技术进步导致了包括起搏器和植入式除颤器在内的医疗设备的激增,旨在恢复正常心律。然而,鉴于人类心脏复杂的时空动态和非线性,预测心律失常的发作以及防止从稳态过渡到不稳定节律一直是一项极具挑战性的任务。除颤电击仍然是致死性室性心律失常的主要临床干预措施,但植入式心律转复除颤器的患者常因误判而遭受不适当电击,生活质量下降。在此,我们旨在全面综述心律失常预测、预防和控制策略的当前进展。我们概述了传统的临床心律失常管理方法,并描述了用于预测异常节律发作和有效抑制心律失常的有前景的潜在起搏技术。我们还从临床角度探讨了弥合基础科学与临床科学之间差距的问题,这将有助于采用有前景的抗心律失常起搏策略。